FLT3-ITD and NPM1 mutations were previously reported to be associated with specific differential gene expression profiles in AML (Figure S1) [25,52]; however the influence of these aberrations on splicing has not been studied thus far. This evidence concerns the gene FLT3 and acute myeloid leukemia.